Article
Quantifying low-frequency revertants in oral poliovirus vaccine using next generation sequencing.
Journal of virological methods - 1 Aug 2017
Sarcey Eric, Serres Aurélie, Tindy Fabrice, Chareyre Audrey, Ng Siemon, Nicolas Marine, Vetter Emmanuelle, Bonnevay Thierry, Abachin Eric, Mallet Laurent
Abstract excerpt
Spontaneous reversion to neurovirulence of live attenuated oral poliovirus vaccine (OPV) serotype 3 (chiefly involving the n.472U>C mutation), must be monitored during production to ensure vaccine safety and consistency. Mutant analysis by polymerase chain reaction and restriction enzyme cleavage (MAPREC) has long been endorsed by the World Health Organization as the preferred in vitro test for this purpose;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
